Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
tom.barr@bioamd.com
Can someone reach out to Mr. Barr about this and any updates? I don't have his email.
We could all benefit from more info.
Thanks in advance.
Good question for Tom Barr.
ZENO is now at about $25M market cap and BIAD is still at $920,000. BIAD own 60%, ZENO owns 40%. What wrong with this picture?
Second that, thank you as well.
Same to u. And I will. Tom always responds to emails the same day which I always find impressive
Same to you. glta
Certainly investing in BIAD vs ZENO has greater upside potential. Plus BIAD is pursuing more than just MIDS. COAG has massive potential too with a new partner. Recall what happened when Sysmex made a small commitment to BIAD? We were at $.22-.23/ share in a hurry from $.03 and still considered undervalued.
Please keep the open line of communication with Tom Barr. Much appreciated.
GLTA
DK
Now up to 350000. Zeno having big volume day as well. Guess a few people dug deeper and realized who actually is majority owner of their tech
Someone threw a little spare coin at this today. A positive sign, mayhaps. $BIAD
Funniest part of whole thing is our partner who only owns 40% has 10 million market cap while we have 900,000
Thanks for sharing. Very promising.
Baby steps but promising. This company is more realistically (conservatively) valued at $3-$5M in a field of like companies in the $30M to $50M market cap range, so current market cap is a bargain.
With a partner this will more fairly valued.
Patience.
But very good news.
DK
I emailed ceo after pr and asked when they thought they would be able to partner tech. Below is his response
Yes, the results were very pleasing.
The advice we have consistently received is that we will only be able to
partner after we have an assay developed on a strip. We will proceed down
that route. However, we do have a plan to try and get some earlier
engagement.
Regards
Tom
Anyone buying more based on Zeno's latest PR?
Mids trial preliminary results are positive
https://finance.yahoo.com/news/zenosense-inc-mids-hybrid-strip-123000417.html;_ylc=X1MDMTE5Nzc4NDE4NQRfZXgDMQRfeXJpZAMzMDZuanQ1ZDByNjZ0BGcDZFhWcFpEeHVjejR3TTJGaU56TTJNaTB4TlRZMUxUTmhOMll0WWpjNFl5MDFPR05pTm1RMU5HTTBaalIxZFdsa1BHNXpQbHBGVGs4PQ0KBGxhbmcDZW4tVVMEb3JpZ19sYW5nA2VuBG9yaWdfcmVnaW9uA1VTBHBvcwMwBHJlZ2lvbgNVUwRzeW1ib2wDWkVOTw--?.tsrc=applewf
Wish you were right, but I have had countless partial fills on penny stocks where the commission ended up exceeding the principal amount of the transaction.
Wtf someone bought 25 shares today. First time in history of market that someone spent more on the transaction fee than the actual shares
Nope. Haven’t emailed him since. It’s a slow crawl it appears
Aoi. Any further word from Tom Barr?
Zenosense has revamped their website
https://www.zenosense.com
Wish it was up 82% with about 10 million or so volume today LOL
Thanks for sharing. Much appreciated.
This is obviously a very risky stock but Bio-AMD with partner Zenosense continues to make steady progress. I'm of the opinion that patience will pay off, but there have been terrible missteps with Sysmex and former CFO in the past. All behind us.
Tom and team trying to move MIDS and COAG forward.
Again, thanks for sharing Tom's response.
I emailed Tom Barr to check on progress of Mids & if still on track. Below is his response
Apologies, we are currently refining the electronics (a new master board
ordered today) which has put the testing back a bit. This stage of the R&D
is frustrating (and normal) but initial indications are that we will be able
to do what we believe we can do. Having been burned on expectations, I am
reluctant to put a timescale on testing results but rest assured I am keen
to get them out there as soon as they available.
Someone else in dire need of 180 today. Bring on the news Zeno.
Expect MIDS results from BIAD partner Zenosense ($ZENO) soon. If positive this should rocket higher.
Positive MIDS results would be huge news. Long awaited.
Good luck all patient longs.
DK
Check out the ask there bruhs - - - Bazinga!
who dumped at $0.016?
someone really needed that 250 bucks, I guess.
:) to the top!
Big Move!
Someone threw 150 bucks at this today.
Buckle up!
Nice find AOI. More progress with MIDS. Sounds very encouraging.
BIAD still has a heartbeat.
Still lots of risk in the company but tangible progress. See you in six weeks after test results.
Good luck all longs
DK
Hahaha. Zenosense is ancient Chinese secret.
Encourage you to keep on Tom aoi and other investors. I write him periodically as well. Since BIAD is no longer reporting it will be more and more difficult learning of their activities. And more important than ever relying on investment community for intel. Keep it coming
Personally think BIAD will pull off an MIDS win or COAG win. Their tech is just too good. Simply need an opportunity to come their way.
If Partner halts payments it's my understanding they forfeit ownership % back to BIAD so would seem unlikely. Am betting they limp along on partner payments to keep operations alive until they can really strike an MIDS deal.
Very curious ZENO report back on progress "in a few weeks". Good luck all longs. This has been a long and frustrating road. Patience may very well pay off.
BIAD IP value of MIDS must be near $3M alone. This is opportunity albeit high risk. US Patent strong indicator of MIDS value.
DK
Makes sense to me. Biad def undervalued based on IP. Don't see how Zenos other IP can be worth anything considering their 10k states they stopped funding it in 2016 and are focused solely on developing Mids. The recent US patent definitely helps to validate the tech for me. I was on the bid all day today but couldn't get any shares.
Sounds like we are solely reliant on the mystery investor. Investor is willing to take shares in lieu of loan repayment if I'm reading correctly so person seems confident.
I emailed Tom Barr a few days ago to ask if Mids is still moving forward and this was his quote
Yes it is. For detection testing purposes we now have a micro fluidic strip with an associated PCB and Hall sensors - the Hybrid strip, which is as close as we can get without going to a full production model. Flow testing appears good. We are currently producing a magnetic jig to suit and will start testing the hybrid strip for its ability to detect assay sized accumulations of nanoparticles shortly.
I used this email and stuck his description of the device into a google search and the Mids med website popped up on first page. Then I did a patent search and saw the patent recently received. Thanks to der kamf for finding Zeno. Would like to know how he came across that since Barr seems pretty tight lipped about everything.
Great DD there. Just browsed through Zenosense's filings. They have little cash but keep borrowing from some investor who keeps funding them and the MIDS partnership. I found the items below interesting in their last 10-Q.
They show that this investor is still funding MIDS joint venture (MML) and that they paid $152k to MML in April 2017. Looks like about $650k has been given by Zeno to MML so far.
At $0.40, ZENO is valued about about $7.2m. BIAD at $0.01 is valued at $450k, so less than the cash that's put into MIDS.
MML is owned 40% by Zeno and 60% by Bio-AMD UK Holdings Limited (“UKH”). We own 70% of UKH (Mitchell and Djennati own 15% each). So that means we own 42% of MML outright. Unless Zeno's other IP is so much more valuable, there is clearly a difference in valuations of the 2 public companies. So an undervaluation of 10X is not that far off based on these #s alone.
Any thoughts?
"On April 2, 2017, the Company issued an unsecured convertible note (the “April 2017 Note”) in the principal amount of $170,000, to the Noteholder in exchange for a loan of $170,000. The Noteholder retained the option to provide the final amount of $90,000 of the New Option Loans. On receipt of these funds, a payment of $152,500 was made to MML in line with the terms of the Third Amendment.
On May 14, 2017, the Company issued an unsecured convertible note (the “ May 14, 2017 Note”) in the principal amount of $50,000, to the Noteholder in exchange for a loan of $50,000. The terms and conditions of the May 14, 2017 Note are the same as the New Loans with the exception of a conversion price of $0.40. The proceeds of the loan will be used for general working capital."
Thanks for info on their Jv partner. Much appreciated
Yes. Must connect dots to sort news since BIAD currently not reporting but keep eye on BIAD partner thru MML, Zenosense. Ticker "ZENO"
MIDS progressing nicely. More news of progress "in coming weeks". Stay tuned. At $400K market cap BIAD biotech undervalued by minimum factor 10x.
"Our joint venture partner in MML has received a United States Patent and Trademark Office grant for the issuance of the central MIDS patent under number 9,678,064 in the U.S., namely: "Immunoassay Apparatus Incorporating Microfluidic Channel".
This is as a result of a patent application originally filed in 2011 by our MML joint venture partner. It is one of a number of applications made in commercially crucial regions for patent protection of the central MIDS detection technology.
The same MIDS patent has already been granted in China. Other applications have also successfully progressed into the national phase in the EU and India. This issuance in the U.S. indicates that these latter territories are also likely to progress to grant and, if so, will establish intellectual property protection in these key commercial regions. The MIDS patents are under license for the exclusive use by MML and will be transferred directly to MML in the event of the conclusion of a relevant commercial deal with a third party.
Carlos Gil, CEO of Zenosense Inc., commented: "This latest grant of the MIDS patent in the U.S. further validates our confidence in the ability of the MML team to deliver this exciting technology. I also expect to be able to provide a further update on development activities in the coming weeks."
Mids is moving forward nicely. Sorry for butchering English language in first post. And. Look here.appears to be a patent for Mids granted earlier this month if I'm reading this correctly
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=%22Bio+amd%22.ASNM.&OS=AN/%22Bio+amd%22&RS=AN/%22Bio+amd%22
First time poster here. Bought this pretty big in 2015-16 w .12 average. Took big hit and sold out at .03 when coag deal fell through. Been buying again in the .01 range. Anyone seen this additional website listed below that I found? Looks like Mids is preceding nicely.
http://midsmed.com
$BIAD waking up? somebody threw a little loose change at it today!
I warned about the pump two years ago but didn't follow my own advice and thought i was "buying low" at one point. Oh, maybe one day these shares will be worth something. It's certainly happened before where nearly worthless stocks took on a new life and made me tens of thousands of $$s.
BIAD a sub penny now ouch!!! I feel bad for all that were led into this POS and couldn't get out at all!!
But only ~$3.8k :) Looked like someone closed a position. I'm still in, but afraid this stock is dead unless they miraculously commercialize something.
368K shares so far today and down 20.53%. Big volume for this one.
Very true statement....
BIAD Volume Alert!
someone actually bought some of this POS today.
Yes, one never knows when an apparently "dormant" or even "defunct" company and its stock can have a major breakthrough and come alive once again with new and old money flowing into buying the stock. I've seen it happen before with other companies.... I'm hoping it will one day be true of BIAD.
ho hum maybe someday....
Followers
|
42
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1616
|
Created
|
10/19/08
|
Type
|
Free
|
Moderators |
Share Structure
Market Value1 $4,879,856 a/o March 28,2013
Shares Outstanding 44,525,966 a/o March 18, 2013
Float 37,000,000 of which 15,000,000 are paper certs.
Authorized Shares 500,000,000
Action Stock Transfer Corporation
2469 E. Fort Union Blvd., Suite 214
Salt Lake City, UT 84121
Note: This is a non dilutive company!!! The share structure has been unchanged for the past 3 years.
Contact details
Bio-Alternative Medical Devices Ltd
Daresbury Science & Innovation Campus
Daresbury Innovation Centre
Keckwick Lane
Daresbury
Cheshire
WA4 4FS United Kingdom
Tel: +44 (0) 1925 606 471
Fax: +44 (0) 1925 606 475
Web site: http://www.bioamd.com
Daily Chart:BIAD
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |